Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Dec 4;35(12):2172-2182.
doi: 10.1093/ndt/gfz278.

Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis

Mohamed E Elsayed  1   2 , Adam D Morris  2 , Xia Li  3 , Leonard D Browne  1 , Austin G Stack  1   4   5
Affiliations
Meta-Analysis

Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis

Mohamed E Elsayed et al. Nephrol Dial Transplant. .

Abstract

Background: Accurate comparisons of haemodialysis (HD) and peritoneal dialysis (PD) survival based on observational studies are difficult due to substantial residual confounding that arises from imbalances between treatments. Propensity score matching (PSM) comparisons confer additional advantages over conventional methods of adjustment by further reducing selection bias between treatments. We conducted a systematic review of studies that compared mortality between in-centre HD with PD using a PSM-based approach.

Methods: A sensitive search strategy identified all citations in the PubMed, Cochrane and EMBASE databases from inception through November 2018. Pooled PD versus HD mortality hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated through random-effects meta-analysis. A subsequent meta-regression explored factors to account for between-study variation.

Results: The systematic review yielded 214 citations with 17 cohort studies and 113 578 PSM incident dialysis patients. Cohort periods spanned the period 1993-2014. The pooled HR for PD versus HD was 1.06 (95% CI 0.99-1.14). There was considerable variation by country, however, mortality risks for PD versus HD remained virtually unchanged when stratified by geographical region with HRs of 1.04 (95% CI 0.94-1.15), 1.14 (95% CI 0.99-1.32) and 0.98 (0.87-1.10) for European, Asian and American cohorts, respectively. Subgroup meta-analyses revealed similar risks for patients with diabetes [HR 1.09 (95% CI 0.98-1.21)] and without diabetes [HR 0.99 (95% CI 0.90-1.09)]. Heterogeneity was substantial (I2 = 87%) and was largely accounted for by differences in cohort period, study type and country of origin. Together these factors explained a substantial degree of between-studies variance (R2 = 90.6%).

Conclusions: This meta-analysis suggests that PD and in-centre HD carry equivalent survival benefits. Reported differences in survival between treatments largely reflect a combination of factors that are unrelated to clinical efficacy.

Keywords: haemodialysis; mortality; peritoneal dialysis.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram.
FIGURE 2
FIGURE 2
Forest plot for meta-analysis of PSM studies comparing mortality risk of PD versus in-centre HD. seTE, standard error of treatment effect.
FIGURE 3
FIGURE 3
Forest plots for meta-analyses of PD versus HD mortality risk by diabetes. seTE, standard error of treatment effect.
None
See this image and copyright information in PMC

References

    1. Pippias M, Kramer A, Noordzij M. et al. The European Renal Association–European Dialysis and Transplant Association Registry Annual Report 2014: a summary. Clin Kidney J 2017; 10: 154–169 - PMC - PubMed
    1. United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2016
    1. ClinicalTrials.gov. Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China. https://ClinicalTrials.gov/show/NCT01413074 (1 June 19, date last accessed)
    1. Korevaar JC, Feith GW, Dekker FW. et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222–2228 - PubMed
    1. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002; 13: 1279–1287 - PubMed